FHL1 Activators
FHL1 Activators are a collection of chemical compounds that bolster the activity of FHL1 through various signaling pathways, ultimately influencing muscle cell function and structure. Phorbol 12-myristate 13-acetate (PMA) and Forskolin, for instance, enhance intracellular signaling via PKC and PKA respectively, leading to enhanced muscle differentiation which may indirectly boost FHL1's role within muscle cells. DNA methyltransferase and histone deacetylase inhibitors, such as 5-Azacytidine and Trichostatin A, can alter gene expression patterns, potentially elevating FHL1 activity by promoting its transcription in muscle cells. Ionomycin and A23187, both calcium ionophores, elevate intracellular calcium levels and can activate calcium-dependent pathways, thereby indirectly supporting the functional enhancement of FHL1 in muscle tissues. Epigallocatechin gallate (EGCG) and Resveratrol, through their effects on kinase activity and sirtuin activation respectively, modulate signaling that may contribute to the structural integrity of muscle cells where FHL1is essential.
Moreover, chemical inhibitors like LY294002 and SB203580, which target the PI3K/Akt and p38 MAPK pathways, respectively, could potentially shift the signaling dynamics to favor the muscle-related functions of FHL1. GW501516, as a PPARδ agonist, supports fatty acid metabolism, potentially enhancing the structural role of FHL1 in muscle cells by improving energy efficiency. Sildenafil, by elevating cGMP levels, can lead to vasodilation and improved muscle function, which in turn could have a positive effect on FHL1's role in muscle tissue. Collectively, these FHL1 Activators work through a diverse array of biochemical mechanisms to support and enhance the functional activity of FHL1, primarily in the context of muscle cell structure and function, without inducing general pathways or affecting the protein's transcription or translation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate a variety of protein targets including transcription factors that may increase FHL1’s functional activity by affecting gene expression in muscle cells. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can lead to the hypomethylation of DNA and potentially increase the expression of genes, including FHL1, thus potentially enhancing its activity in muscle cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor which can lead to a more relaxed chromatin structure and potentially enhance the transcription of genes including FHL1, possibly boosting its functional role in muscle cells. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which may activate calcium-dependent signaling pathways and potentially enhance FHL1 activity indirectly by affecting muscle cell function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitory activity. It may enhance FHL1 function by modulating signaling pathways involved in muscle cell differentiation and survival, where FHL1 is a key structural component. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could lead to altered signaling downstream of PI3K/Akt pathway, potentially enhancing FHL1 function by affecting cellular processes in muscle cells where FHL1 plays a structural role. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may shift signaling equilibria to favor pathways where FHL1 is functionally important, such as in muscle cell differentiation and stress response. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, potentially augmenting calcium-dependent signaling pathways that could enhance the structural and functional roles of FHL1 in muscle cells. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 is a PPARδ agonist that may enhance fatty acid metabolism and muscle function, potentially indirectly enhancing the structural role of FHL1 in muscle cells through improved cellular energy dynamics. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which is involved in deacetylating histones and other proteins, potentially enhancing FHL1 activity by influencing gene expression related to muscle structure and function. | ||||||